Quest Diagnostics Inc
(DGX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,597 | 96,777 | 113,854 | 89,840 | 149,427 |
| Receivables | 613,638 | 522,131 | 576,461 | 597,667 | 548,400 |
| Inventories | 67,068 | 60,899 | 59,015 | 57,930 | 51,533 |
| Income taxes - deferred | 116,386 | 102,700 | 139,812 | 146,782 | 152,981 |
| TOTAL | $906,920 | $824,443 | $930,145 | $933,814 | $949,867 |
| Non-Current Assets | |||||
| PPE Net | 583,303 | 570,149 | 571,516 | 568,994 | 519,944 |
| Intangibles | 2,537,625 | 1,810,933 | 1,811,713 | 1,802,481 | 1,378,562 |
| Other Non-Current Assets | 158,447 | 118,672 | 152,363 | 146,196 | 157,343 |
| TOTAL | $3,279,375 | $2,499,754 | $2,535,592 | $2,517,671 | $2,055,849 |
| Total Assets | $4,186,295 | $3,324,197 | $3,465,737 | $3,451,485 | $3,005,716 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 80,624 | 26,032 | 251,100 | 301,768 | 1,405 |
| Accounts payable and accrued liabilities | 592,299 | 609,945 | 610,407 | 644,813 | 622,282 |
| TOTAL | $672,923 | $635,977 | $861,507 | $946,581 | $623,687 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,144,355 | 796,507 | 796,778 | 820,819 | 820,190 |
| Other Non-Current Liabilities | 125,942 | 122,850 | 129,726 | 114,091 | 116,241 |
| TOTAL | $1,270,297 | $919,357 | $926,504 | $934,910 | $936,431 |
| Total Liabilities | $1,943,220 | $1,555,334 | $1,788,011 | $1,881,491 | $1,560,118 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 210,668 | 210,362 | 195,593 | 194,849 | 194,012 |
| Common Shares | 1,053 | 980 | 977 | 974 | 967 |
| Retained earnings | 47,264 | -40,772 | -122,469 | -209,086 | -296,237 |
| Other shareholders' equity | -11,466 | -8,856 | -8,367 | -10,373 | -13,659 |
| TOTAL | $2,243,075 | $1,768,863 | $1,677,726 | $1,569,994 | $1,445,598 |
| Total Liabilities And Equity | $4,186,295 | $3,324,197 | $3,465,737 | $3,451,485 | $3,005,716 |